Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2003
04/02/2003EP1296982A1 1-(heteroaryl-phenyl)-condensed pyrazol derivatives as factor xa inhibitors
04/02/2003EP1296981A2 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
04/02/2003EP1296980A1 Thiazolidinedione salt for treatment of diabetes mellitus
04/02/2003EP1296978A2 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity
04/02/2003EP1296977A1 Heteroaryl-phenyl substituted factor xa inhibitors
04/02/2003EP1296976A1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them
04/02/2003EP1296975A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
04/02/2003EP1296974A2 2-cyanopyrrolidine derivatives and their use as medicaments
04/02/2003EP1296972A1 Arylmethylamine derivatives for use as tryptase inhibitors
04/02/2003EP1296971A2 2-fluorobenzenesulfonyl compounds for the treatment of inflammation
04/02/2003EP1296970A1 Method for the preparation of citalopram
04/02/2003EP1296967A1 Quinolinyl and benzothiazolyl ppar-gamma modulators
04/02/2003EP1296961A1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists
04/02/2003EP1296959A1 Methods and compositions utilizing quinazolinones
04/02/2003EP1296958A1 Iminopyrimidine nmda nr2b receptor antagonists
04/02/2003EP1296956A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors
04/02/2003EP1296954A1 Bicyclic lactams and sulfonamides with 5-ht1a-affinity and use thereof for preventing and treating cerebral ischaemia
04/02/2003EP1296951A1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3']bipyridinyl in pure crystalline form and process for synthesis
04/02/2003EP1296950A2 Aminopiperidines for use as glyt-1 inhibitors
04/02/2003EP1296949A2 Piperidine amides as modulators of chemokine receptor activity
04/02/2003EP1296948A2 Novel gamma crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same.
04/02/2003EP1296947A1 $g(A) CRYSTALLINE FORM OF PERINDOPRIL TERT-BUTYLAMINE SALT
04/02/2003EP1296946A1 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
04/02/2003EP1296945A1 Sulfonamide derivatives
04/02/2003EP1296944A1 Sulfonamide derivatives
04/02/2003EP1296943A1 Amino acid derivatives and their use as medicines
04/02/2003EP1296942A1 Glucagon antagonists/inverse agonists
04/02/2003EP1296941A2 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants
04/02/2003EP1296940A1 Amidine derivatives as selective antagonists of nmda receptors
04/02/2003EP1296938A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
04/02/2003EP1296936A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones
04/02/2003EP1296934A1 Cyclohexylamine derivatives as subtype selective nmda receptor antagonists
04/02/2003EP1296931A2 Polyamine analogues as cytotoxic agents
04/02/2003EP1296929A2 Modified forms of pharmacologically active agents and uses therefor
04/02/2003EP1296924A1 Method for producing a non-fatty softener based on wax-esters
04/02/2003EP1296923A2 Aspirin-triggered lipid mediators
04/02/2003EP1296724A1 Bioadhesive composition and methods of preparation and use
04/02/2003EP1296723A1 A medicinal aerosol formulation
04/02/2003EP1296716A2 New formulation
04/02/2003EP1296713A1 Immunostimulatory oligodeoxynucleotides
04/02/2003EP1296712A2 Hiv-1 vaccines and screening methods therefor
04/02/2003EP1296708A1 Use of secretin-receptor ligands in treatment of cystic fibrosis (cf) and chronic obstructive pulmonary disease (copd)
04/02/2003EP1296707A1 Methods of treating viral diseases with il-18 and il-18 combinations
04/02/2003EP1296703A1 Non-antibacterial tetracycline as anti-fungal agents
04/02/2003EP1296700A1 Anti-carcinogenic activity of hydroxylated chalcone compounds extracted from licorice root
04/02/2003EP1296699A1 Therapeutic agents - iii
04/02/2003EP1296698A1 Therapeutic agents - ii
04/02/2003EP1296697A1 Therapeutic agents - i
04/02/2003EP1296691A2 Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections
04/02/2003EP1296690A2 METHOD FOR THE TREATMENT OR PREVENTION OF i FLAVIVIRUS /i INFECTIONS USING NUCLEOSIDE ANALOGUES
04/02/2003EP1296689A2 Method of administering bisphosphonates
04/02/2003EP1296688A2 Bactericidal antimicrobial methods and compositions for use in treating gram positive infections comprising an antibiotic potentiator having acyl hydrazide, oxy amide or 8-hydroxy quinoline structure
04/02/2003EP1296687A2 Treatment of male sexual dysfunction
04/02/2003EP1296686A2 Praziquantel compositions for treating diseases due to sarcocystis, neospora, toxoplasma and isospora
04/02/2003EP1296685A1 Sustained-release preparations of quinolone antibiotics and method for preparation thereof
04/02/2003EP1296684A2 Treatment of gastroesophageal reflux disease using piperidine derivatives
04/02/2003EP1296683A2 Methods of treating neutrophil-related diseases with topical anesthetics
04/02/2003EP1296682A2 Chemosensitizer
04/02/2003EP1296681A2 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl)
04/02/2003EP1296680A2 The method of treating drug resistant mycobacterium tuberculosis infection
04/02/2003EP1296679A1 Dermal therapeutic system containing non-steroidal antiphlogistics with selective cox-2 inhibition
04/02/2003EP1296677A2 Solid valsartan pharmaceutical compositions
04/02/2003EP1296676A1 Use of indole-3-acetic acid derivatives in medicine
04/02/2003EP1296675A2 Compositions based on aminoacids, suitable for the treatment of heart failure
04/02/2003EP1296674A2 Use of substituted indole compounds for increasing nitric oxide synthase activity
04/02/2003EP1296673A1 Antimicrobial coatings
04/02/2003EP1296672A1 Stable pharmaceutical product and formulation
04/02/2003EP1296671A2 Gabapentin analogues for sleep disorders
04/02/2003EP1296670A1 Therapeutic combinations of fatty acids
04/02/2003EP1296669A1 COMBINATION PREPARATION CONSISTING OF $g(V)-3-FATTY ACIDS AND OF CONJUGATED LINOLEIC ACIDS FOR TREATING IMMUNOLOGICALLY ORIENTED CLINICAL SIGNS
04/02/2003EP1296668A2 Compositions based on aminoacids, suitable for improving muscle performance
04/02/2003EP1296667A2 Use of an aluminium and ethylenediamine-tetraacetic complex for preventing and/or treating urticaria
04/02/2003EP1296666A2 Improved thyroid hormone formulations
04/02/2003EP1296665A1 Analgesic and anti-inflammatory compositions containing cox-2 inhibitors
04/02/2003EP1296664A2 Propofol for treatment of sepsis
04/02/2003EP1296662A1 Dermal therapeutic system containing 2-(3-benzophenyl)-propionic acid or '0-(2,6-dichloranilino)-phenyl!-ethanoic acid
04/02/2003EP1296661A2 Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities
04/02/2003EP1296659A1 Pharmaceutical compositions of 2'-deoxy-2'-(fluoromethylene)cytidine
04/02/2003EP1296657A1 Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates
04/02/2003EP1296656A2 Method for preparing a composition
04/02/2003EP1296653A1 Method for formulating healthcare products with enhanced stability
04/02/2003EP1296652A1 Topical pharmaceutical formulations and methods of treatment
04/02/2003EP1296651A1 Method of making particles for use in a pharmaceutical composition
04/02/2003EP1296650A2 Methods and compositions for treating pain of the mucous membrane
04/02/2003EP1296649A2 Pharmaceutical compositions comprising an opioid analgesic
04/02/2003EP1296648A1 Micellar pharmaceutical compositions for buccal and pulmonary application
04/02/2003EP1296647A2 Polymeric micelle compositions
04/02/2003EP1296646A2 Oral pharmaceutical compositions containing terbinafine
04/02/2003EP1296645A2 Methods for treating inflammation-mediated conditions of the eye
04/02/2003EP1296644A2 Systems and methods for treating a mucosal surface
04/02/2003EP1296642A1 Use of creatine and/or creatine derivatives in cosmetic or dermatological preparations
04/02/2003EP1296633A1 Medicinal product package for eradication therapy
04/02/2003EP1296552A2 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5
04/02/2003EP1246627A4 Polyanhydrides with biologically active degradation products
04/02/2003EP1228069B1 Bicyclic and tricyclic heteroaromatic compounds
04/02/2003EP1226143B1 Imidazopyridine derivatives used as phosphodiesterase vii inhibitors
04/02/2003EP1212312B1 Novel derivatives of flavones, xanthones and coumarins
04/02/2003EP1211942B1 Method for the production of polyvinylpyrrolidone-iodine in an aqueous solution
04/02/2003EP1208100B1 Selective antagonists of a2b adenosine receptors
04/02/2003EP1192155B1 New bispidine compounds useful in the treatment of cardiac arrhythmias
1 ... 5516 5517 5518 5519 5520 5521 5522 5523 5524 5525 5526 5527 5528 5529 5530 5531 5532 5533 5534 5535 5536 ... 7860